Recursion Pharmaceuticals reports fourth-quarter and full-year 2025 results Wednesday before the market opens, with investors scrutinizing whether the AI-driven biotech can translate its massive data ...

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI ...

South Portland, Maine--(Newsfile Corp. - February 3, 2026) - As AI systems increasingly control life-and-death decisions--from autonomous vehicles to medical diagnostics to financial markets--a ...

AppLovin (NASDAQ:APP) executives used a Morgan Stanley conference appearance to reiterate their view that the company’s core gaming advertising business still has meaningful runway, while outlining ...

Delivered first clinical validation of the Recursion full stack AI Operating System in FAP, demonstrating translation from AI-driven biological insight to meaningful patient outcomes; multiple clinica ...

By Joseph Tulloch For years, AI safety experts have been warning of a future moment where AI models become advanced enough to ...

AI infrastructure can't evolve as fast as model innovation. Memory architecture is one of the few levers capable of accelerating deployment cycles. Enter SOCAMM2 ...

The unbridled hype of the mid-2020s is finally colliding with the structural and infrastructure limits of 2026.

Recursion Pharmaceuticals (RXRX) ended the recent trading session at $3.53, demonstrating a +2.02% change from the preceding day's closing price. This move outpaced the S&P 500's daily gain of 0.56%.

AI development is often framed as a race among countries, companies and academic researchers. But figuring out who’s actually ...

LinkDaddy announces the launch of a patent-compliant website infrastructure service, delivering four-patent-compliant builds ...

It’s more than just code. Scientists have found a way to "dial" the hidden personalities of AI, from conspiracy theorists to social influencers.